|
POLR3C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.255600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.364200E-02 |
| Normal-vs-Stage2 |
8.680000E-01 |
| Normal-vs-Stage3 |
1.417820E-01 |
| Normal-vs-Stage4 |
2.361000E-01 |
| Stage1-vs-Stage2 |
1.438040E-01 |
| Stage1-vs-Stage3 |
1.466070E-02 |
| Stage1-vs-Stage4 |
8.020400E-03 |
| Stage2-vs-Stage3 |
2.148800E-01 |
| Stage2-vs-Stage4 |
2.811800E-01 |
| Stage3-vs-Stage4 |
8.329800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.972200E-01 |
| Normal-vs-AfricanAmerican |
9.444000E-01 |
| Normal-vs-Asian |
7.965400E-01 |
| Caucasian-vs-AfricanAmerican |
5.207600E-01 |
| Caucasian-vs-Asian |
9.413800E-01 |
| AfricanAmerican-vs-Asian |
7.458000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.042100E-02 |
| Normal-vs-Female |
3.913700E-02 |
| Male-vs-Female |
2.018700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.573800E-01 |
| Normal-vs-Extreme_Weight |
9.104400E-03 |
| Normal-vs-Obese |
3.523400E-01 |
| Normal-vs-Extreme_Obese |
1.823680E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.410300E-02 |
| Normal_Weight-vs-Obese |
7.540200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.812200E-02 |
| Extreme_Weight-vs-Obese |
1.682580E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.264600E-01 |
| Obese-vs-Extreme_Obese |
3.904500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.869790E-01 |
| Normal-vs-Age(41-60Yrs) |
9.949200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.310100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.311360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.056300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.232200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.010500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.794100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.773400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.759400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.700000E-03 |
| Normal-VS-Type2 PRCC |
2.187400E-01 |
| Normal-VS-KIRP CIMP |
1.835760E-01 |
| Normal-VS-Unclassified PRCC |
6.192600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.777200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.384300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.549800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.466800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.159400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.369180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.765000E-01 |
| Normal-vs-N1 |
4.660300E-03 |
| Normal-vs-N2 |
8.106200E-01 |
| N0-vs-N1 |
1.337450E-03 |
| N0-vs-N2 |
8.305000E-01 |
| N1-vs-N2 |
1.826240E-01 |
|
|
